FGH10019: Unlocking the Power of SREBP Inhibition

In the dynamic world of scientific research and development, the pursuit of innovative compounds that can unlock new frontiers is a constant challenge. FGH10019, a novel inhibitor of the sterol regulatory element-binding protein (SREBP) pathway, stands as a testament to this pursuit. With its potent IC50 of 1 μM, this compound offers a unique opportunity to explore the intricate mechanisms underlying lipid metabolism and cellular homeostasis.

FGH10019 is a meticulously crafted chemical compound, boasting a purity of 98.93% and a well-defined molecular structure. Its InChI code, InChI=1S/C18H19N3O2S2/c1-3-4-16-11-14(9-10-19-16)18-20-17(12-24-18)13-5-7-15(8-6-13)21-25(2,22)23, and SMILES string, CCCc1cc(-c2nc(-c3ccc(NS(C)(=O)=O)cc3)cs2)ccn1, provide a unique identifier that allows researchers to delve into its intricate details.

Unraveling the Potential of SREBP Inhibition

The sterol regulatory element-binding protein (SREBP) pathway plays a pivotal role in the regulation of lipid metabolism, making it a prime target for therapeutic interventions. FGH10019's ability to inhibit this pathway at a potent IC50 of 1 μM opens up a world of possibilities for researchers exploring the management of metabolic disorders, cardiovascular diseases, and even certain types of cancer.

By disrupting the SREBP signaling cascade, FGH10019 can potentially modulate the expression of genes involved in lipid synthesis, cholesterol homeostasis, and energy metabolism. This targeted approach holds the promise of developing novel therapies that address the root causes of these complex health challenges, rather than merely treating the symptoms.

Versatile Applications in Scientific Exploration

FGH10019's versatility extends beyond its SREBP inhibition capabilities. As a Fatty Acid Synthase inhibitor and a Membrane Transporter/Ion Channel modulator, this compound can serve as a valuable tool in a wide range of scientific endeavors.

In the realm of pharmaceutical research, FGH10019 can be leveraged as a starting point for the synthesis of innovative drug candidates targeting metabolic disorders, cardiovascular diseases, and even certain types of cancer. Its unique chemical structure and potent inhibitory activity make it a promising lead compound for further optimization and development.

Beyond the pharmaceutical domain, FGH10019's applications extend to the field of agrochemicals. Its ability to modulate membrane transporters and ion channels can contribute to the development of advanced crop protection agents, helping to safeguard agricultural productivity and sustainability.

Ensuring Optimal Storage and Handling

To maintain the integrity and purity of FGH10019, it is essential to adhere to proper storage and handling protocols. As a powder, the compound should be stored at -20°C for up to 3 years, ensuring its stability and potency. If dissolved in a solvent, it is recommended to store it at -80°C for up to 1 year.

When handling FGH10019, appropriate safety measures must be taken, including the use of personal protective equipment (PPE) and working in a well-ventilated area. The compound's hazard information, denoted by the H100:H100 statement, underscores the importance of exercising caution and following established safety guidelines.

Unlocking the Potential: A Collaborative Journey

FGH10019 represents a remarkable opportunity for researchers, scientists, and innovators to push the boundaries of scientific discovery. By harnessing the power of this potent SREBP inhibitor, the scientific community can embark on a collaborative journey to uncover new frontiers in the realms of metabolic regulation, drug development, and agricultural advancements.

Explore the